Home>
Stocks>
Pharma Stocks

Pharma Stocks

Name: Best Pharma Stocks - Pharma Sector Stocks to Buy
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Pharmaceutical companies manufacture drugs that are used in medicines to cure illness ranging from cancer to a common cold. India has some of the world's largest pharmaceutical companies who have a strong reputation for mass producing generic drugs.

Live Share Market

List of Pharma Stocks

Stock Categories

Filter

Sort by

Name	Price	M Cap	Analyst Rating	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Div Yld	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Sun Pharmaceutical Industries Ltd	₹1,682.60	Large Cap	BUY	1975.69	4.06%	6.08%	91.55%	239.85%	36.9	51.74	17.11	0.58	0.92%	2160.64 Cr	-25.94%	13.8%	222.39%	12815.58	-4.62%	8.42%	36.02%	20.88%	-22.35%	4.97%	137.02%	Basic Materials	403712.1	17.83%	16.29%	45.76	1309704
Divis Laboratories Ltd	₹6,778.50	Large Cap	HOLD	6439.76	46.14%	48.15%	81.84%	204.61%	82.13	51.74	6.75	0.77	0.87%	662 Cr	12.39%	-12.28%	-19.37%	2585	11.47%	1%	12.56%	20.4%	0.83%	-13.15%	-28.37%	Basic Materials	179947.88	12.04%	16.27%	60.38	968781
Cipla Ltd	₹1,484.00	Large Cap	BUY	1649.51	-4.2%	-2.19%	53.62%	132.53%	22.73	51.74	3.63	0.73	1.11%	1225.02 Cr	-22.65%	27.33%	106.72%	6597.72	-5.23%	6.88%	26.58%	19.21%	-18.38%	19.13%	63.32%	Basic Materials	119870.28	17.17%	21.4%	65.52	1554680
Torrent Pharmaceuticals Ltd	₹3,404.90	Large Cap	BUY	3685.62	13.26%	15.28%	124.3%	184.61%	60.3	51.74	14.42	0.64	0.19%	498 Cr	-0.99%	15.39%	145.92%	2909	5.32%	7.35%	35.36%	16.6%	-6%	7.49%	81.69%	Basic Materials	115232.11	26.18%	26.84%	56.47	539810
Mankind Pharma Ltd	₹2,696.50	Large Cap	BUY	2717.76	23.48%	25.5%	89.59%	89.59%	54.64	51.74	9.56	0.61	NA	424.65 Cr	10.44%	48.26%	50.17%	3079.37	-3.73%	18.12%	66.3%	18.79%	14.72%	25.52%	-9.7%	Pharmaceuticals	111292.31	20.95%	25.77%	48.47	2132999
Dr Reddys Laboratories Ltd	₹1,250.60	Large Cap	HOLD	1261.72	-9.99%	-7.97%	37.55%	54.91%	18.42	51.74	3.31	0.61	0.7%	1586.7 Cr	13%	2.64%	162.32%	8506	1.76%	16.54%	51.51%	17.54%	11.04%	-11.93%	73.14%	Basic Materials	104372.8	20.15%	25.47%	68.65	1035555
Zydus Lifesciences Ltd	₹968.45	Mid Cap	HOLD	967.2	-20.5%	-18.48%	161.07%	173.15%	21.53	51.74	6.43	0.78	0.3%	1248.8 Cr	24.35%	92.98%	80.31%	6290.2	22.77%	13.4%	35.71%	19.72%	1.28%	70.18%	32.86%	Basic Materials	97448.73	23.45%	22.73%	38.31	1409414
Lupin Ltd	₹1,926.10	Mid Cap	BUY	2235.06	3.08%	5.09%	200.55%	124.71%	26.77	51.74	3.58	0.8	0.49%	782.38 Cr	-8.9%	332.35%	57.63%	5562.2	-1%	20.25%	31.97%	9.67%	-7.98%	259.55%	19.44%	Basic Materials	87968.09	11.92%	13.96%	42.47	624180
Abbott India Ltd	₹34,295.00	Mid Cap	BUY	34047	17.91%	19.93%	73.67%	125.44%	0	51.74	15.48	0.49	NA	367.04 Cr	1.74%	16.35%	0%	1604.59	-0.6%	14.52%	0%	14.18%	2.35%	1.6%	0%	Basic Materials	72876.88	34.88%	44.71%	35.67	2513
Aurobindo Pharma Ltd	₹1,138.60	Mid Cap	BUY	1354.39	-19.2%	-17.18%	107.49%	35.54%	19.04	51.74	3.24	0.84	0.41%	902.83 Cr	6.77%	64.4%	-40.59%	8381.12	6.18%	16.68%	17.06%	10.93%	0.56%	40.89%	-49.25%	Basic Materials	66714.97	10.35%	11.74%	54.09	819943
Glenmark Pharmaceuticals Ltd	₹2,219.20	Mid Cap	BUY	1822.58	55.58%	57.6%	483.23%	433.72%	59.82	51.74	1.18	0.74	0.26%	4.38 Cr	-98.74%	-479.84%	-247.77%	3220.13	-2.48%	1.98%	7.94%	-12.14%	-98.71%	-472.45%	-236.9%	Basic Materials	62626	6.98%	9.75%	-50.8	3573890
Alkem Laboratories Ltd	₹4,840.70	Mid Cap	HOLD	5179.67	-12.1%	-10.09%	50.71%	90.86%	26.73	51.74	5.6	0.58	0.81%	323.01 Cr	-49.59%	79.92%	11.97%	3143.75	-6.83%	9.21%	42.89%	14.3%	-45.9%	64.75%	-21.64%	Basic Materials	57877.83	17.56%	17.28%	151.52	76088

Why to invest in Pharma Stocks

Research and Development Focus: Pharma stocks are driven by a strong emphasis on research and development for the creation of innovative drugs.
Global Health Impact: Investing in pharma stocks aligns with contributing to global health and addressing medical challenges.
Stable Revenue Streams: These stocks often provide stable revenues due to consistent demand for medications and healthcare solutions.
Regulatory Resilience: Pharma stocks showcase resilience to regulatory changes, contributing to a stable investment environment.
Defensive Characteristics: Considered defensive, pharma stocks can offer stability during economic downturns.

Advantages of investing in Pharma Stocks

Innovation and Breakthroughs
Pharma stocks offer exposure to companies at the forefront of medical innovation, driving breakthrough treatments and advancements.
Global Health Trends
Investing in pharma stocks aligns with addressing global health challenges, positioning these stocks for sustained long-term growth.
Regulatory Stability
Pharma stocks demonstrate resilience to regulatory changes, providing a stable investment environment for investors seeking predictability in the sector.

Points to consider before investing in Pharma Stocks

Regulatory Environment
Assess the regulatory landscape affecting pharma stocks to understand potential impacts on operations and financials.
Pipeline of Innovation
Examine the innovation pipeline of pharma companies, assessing their potential for developing new drugs and medical technologies.
Financial Health
Thoroughly analyze the financial health of healthcare companies, considering factors like revenue growth, profitability, and debt levels.
Demographic Trends:
Consider demographic trends and their influence on healthcare needs, as an aging population often leads to increased demand for medical services.
Competition and Market Position
Evaluate the competitive landscape and market positioning of pharma stocks to identify companies with a strong foothold in the industry
Global Health Issues
Stay informed about global health issues, as they can significantly impact the demand for healthcare services and pharmaceuticals, influencing the performance of pharma stocks.

Check More Stocks

Name	Price	Analyst Rating	M Cap	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Adani Power Ltd	₹609.55	BUY	LARGE CAP	633.67	-15.99%	-13.97%	112.57%	1656.63%	18.92	30.15	4.74	1.17	2599.23 Cr	-11.59%	-38.79%	159.58%	14237.4	4.14%	11.62%	102.82%	22.68%	-15.11%	-45.16%	27.99%	Utilities	235099.71	26.75%	21.83%	33.06	7403596
Tata Motors Ltd	₹674.50	HOLD	LARGE CAP	765.93	-36.18%	-34.16%	53.23%	553.59%	10.81	36.08	7.42	1.28	8556 Cr	55.99%	-11.5%	-350.55%	118927	6.28%	1.31%	57.91%	6.4%	46.77%	-12.64%	-258.67%	Consumer Cyclical	248314.63	17.15%	18.21%	76.49	7748550
AWL Agri Business Ltd	₹268.00	BUY	MID CAP	322.67	-21.76%	-19.75%	-57.03%	-0.09%	28.42	61.04	3.57	0.8	176.52 Cr	-55.1%	581.65%	50.22%	18229.59	8.26%	24.3%	17.57%	1.83%	-58.53%	448.39%	27.77%	FMCG	34831.39	13.78%	20.03%	8.98	965397
Infosys Ltd	₹1,570.30	BUY	LARGE CAP	1694	-10.03%	-8.01%	9.78%	88.98%	24.35	32.31	7.47	1.08	7038 Cr	3.17%	1.91%	20.79%	40925	-2.01%	6.06%	33.99%	16.41%	5.28%	-3.91%	-9.85%	Technology	652345.43	30.35%	39.64%	64.52	9173426
Tata Steel Ltd	₹160.44	BUY	LARGE CAP	162.57	-5.81%	-3.79%	81.53%	372.86%	58.55	24.16	1.21	1.35	1200.88 Cr	306.4%	-164.64%	-92.4%	55706.99	4.65%	-4.64%	-10.42%	1.45%	288.34%	-167.79%	-91.51%	Industrials	200285.71	9%	10.52%	2.54	15152964
Yes Bank Ltd	₹19.99	SELL	MID CAP	17.09	-26.24%	-24.22%	50.3%	-2.25%	25.3	15.1	1.62	0.96	744.53 Cr	20.21%	74.66%	-136.84%	9437.85	0.23%	23.98%	42.4%	3.9%	19.93%	40.88%	-125.87%	Financial Services	62703.14	2.45%	NA	0.45	81039620
Eternal Ltd	₹270.60	BUY	LARGE CAP	282.3	16.07%	18.09%	402.04%	114.76%	451		6.95	1.23	39 Cr	-33.9%	-136.15%	-142.99%	5833	7.92%	71.13%	507.58%	2.9%	-38.75%	-121.12%	-107.08%	Technology	261138.49	5.15%	5.18%	0.4	50184664
ITC Ltd	₹419.40	BUY	LARGE CAP	500.39	-6.35%	-9.5%	42.87%	111.07%	15.3	28.62	7.55	0.64	19807.88 Cr	295.12%	68.92%	126.1%	18565.05	-0.08%	10.88%	24.16%	46.54%	295.44%	52.34%	82.11%	Consumer Defensive	524985.72	27.91%	36.71%	28.01	6896989
Wipro Ltd	₹254.25	HOLD	LARGE CAP	254.71	-11.16%	-9.15%	29.11%	93.52%	20.23	32.31	4.36	1.16	3588.1 Cr	6.58%	18.95%	7.96%	22504.2	0.83%	-0.75%	12.33%	14.84%	5.7%	19.85%	-3.89%	Technology	266517.83	17.89%	21.54%	12.62	10388421
HDFC Bank Ltd	₹1,983.00	BUY	LARGE CAP	2212.68	20.23%	22.25%	45.59%	88.29%	21.37	15.1	2.5	0.88	18834.88 Cr	6.67%	39.27%	101.24%	120268.76	7.2%	99.35%	161.73%	15.7%	-0.49%	-30.13%	-23.11%	Financial Services	1520547.28	16.88%	NA	86.15	6544425

Frequently Asked Questions

What are pharma stocks?

Pharma stocks represent publicly traded companies involved in researching, developing, manufacturing, and marketing pharmaceutical drugs and treatments. These companies play a vital role in advancing healthcare and stand to benefit from successful product launches and growing healthcare needs.

What are the risks of pharma stocks?

High R&D Costs: Developing new drugs is expensive and time-consuming, with a high risk of failure during clinical trials, potentially impacting stock prices.
Regulatory Hurdles: Strict government regulations can delay drug approvals, hindering a company's ability to bring products to market.
Patent Expiry: Once a drug's patent expires, generic competition can significantly reduce profitability.
Economic Downturns: Healthcare spending can be impacted by economic downturns, potentially affecting pharma companies' revenues

How to identify promising pharma stocks?

Strong R&D Pipeline: Look for companies with a robust pipeline of drugs in various stages of development.
Focus on Innovation: Companies prioritising innovative therapies or addressing unmet medical needs can be attractive.
Financials: Evaluate a company's financial health, considering factors like profitability, debt levels, and cash flow.
Regulatory Environment: Understanding the regulatory landscape in the company's target markets is crucial.

Is diversification important when investing in Pharmaceuticals Sector Stocks?

Diversification is crucial when investing in pharmaceutical sector stocks. While the industry presents significant growth opportunities, it also entails considerable risks and uncertainties, including patent expirations, regulatory hurdles, and potential clinical trial failures, among others.

By spreading investments across multiple pharmaceutical companies, investors can mitigate risk and lessen the potential negative impact on overall returns. This approach allows for a balance between potential gains and losses, ultimately improving the performance and stability of returns.

How do changes in government policies and regulations affect pharmaceutical sector stocks?

Government policy changes can have a significant impact on pharmaceutical sector stocks. In particular, government decisions related to reimbursement rates, intellectual property rights, and drug pricing can greatly influence the market potential and profitability of pharmaceutical companies.

Explore Stocks Category:

INDmoney is 100% Safe and Secure!

Your security and privacy are our top priority!

27001:2022
ISO Certified
Audited by
cert-in empanelled auditors
AES 256-BIT
SSL Secured